![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:A2M-AFMID (FusionGDB2 ID:HG2TG125061) |
Fusion Gene Summary for A2M-AFMID |
![]() |
Fusion gene information | Fusion gene name: A2M-AFMID | Fusion gene ID: hg2tg125061 | Hgene | Tgene | Gene symbol | A2M | AFMID | Gene ID | 2 | 125061 |
Gene name | alpha-2-macroglobulin | arylformamidase | |
Synonyms | A2MD|CPAMD5|FWP007|S863-7 | FKF|KF|KFA | |
Cytomap | ('A2M')('AFMID') 12p13.31 | 17q25.3 | |
Type of gene | protein-coding | protein-coding | |
Description | alpha-2-macroglobulinC3 and PZP-like alpha-2-macroglobulin domain-containing protein 5alpha-2-M | kynurenine formamidaseKFaseN-formylkynurenine formamidaseprobable arylformamidase | |
Modification date | 20200328 | 20200313 | |
UniProtAcc | . | Q63HM1 | |
Ensembl transtripts involved in fusion gene | ENST00000318602, ENST00000542567, | ||
Fusion gene scores | * DoF score | 15 X 18 X 6=1620 | 6 X 6 X 5=180 |
# samples | 20 | 8 | |
** MAII score | log2(20/1620*10)=-3.01792190799726 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/180*10)=-1.16992500144231 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: A2M [Title/Abstract] AND AFMID [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | A2M(9243915)-AFMID(76203648), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | A2M | GO:0001869 | negative regulation of complement activation, lectin pathway | 12538697 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Top |
Fusion Gene ORF analysis for A2M-AFMID |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for A2M-AFMID |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for A2M-AFMID |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:9243915/:76203648) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | AFMID |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Catalyzes the hydrolysis of N-formyl-L-kynurenine to L-kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites. {ECO:0000255|HAMAP-Rule:MF_03014}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for A2M-AFMID |
![]() |
Top |
Fusion Gene PPI Analysis for A2M-AFMID |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for A2M-AFMID |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for A2M-AFMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | A2M | C0002395 | Alzheimer's Disease | 3 | CTD_human |
Hgene | A2M | C0011265 | Presenile dementia | 3 | CTD_human |
Hgene | A2M | C0276496 | Familial Alzheimer Disease (FAD) | 3 | CTD_human |
Hgene | A2M | C0494463 | Alzheimer Disease, Late Onset | 3 | CTD_human |
Hgene | A2M | C0546126 | Acute Confusional Senile Dementia | 3 | CTD_human |
Hgene | A2M | C0750900 | Alzheimer's Disease, Focal Onset | 3 | CTD_human |
Hgene | A2M | C0750901 | Alzheimer Disease, Early Onset | 3 | CTD_human |
Hgene | A2M | C0011570 | Mental Depression | 2 | PSYGENET |
Hgene | A2M | C0011581 | Depressive disorder | 2 | PSYGENET |
Hgene | A2M | C0024121 | Lung Neoplasms | 2 | CTD_human |
Hgene | A2M | C0242379 | Malignant neoplasm of lung | 2 | CTD_human |
Hgene | A2M | C0007102 | Malignant tumor of colon | 1 | CTD_human |
Hgene | A2M | C0009375 | Colonic Neoplasms | 1 | CTD_human |
Hgene | A2M | C0019202 | Hepatolenticular Degeneration | 1 | CTD_human |
Hgene | A2M | C0022660 | Kidney Failure, Acute | 1 | CTD_human |
Hgene | A2M | C0023890 | Liver Cirrhosis | 1 | CTD_human |
Hgene | A2M | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Hgene | A2M | C0024115 | Lung diseases | 1 | CTD_human |
Hgene | A2M | C0027726 | Nephrotic Syndrome | 1 | CTD_human |
Hgene | A2M | C0206669 | Hepatocellular Adenoma | 1 | CTD_human |
Hgene | A2M | C0239946 | Fibrosis, Liver | 1 | CTD_human |
Hgene | A2M | C1527352 | Hepatic Form of Wilson Disease | 1 | CTD_human |
Hgene | A2M | C1565662 | Acute Kidney Insufficiency | 1 | CTD_human |
Hgene | A2M | C2239176 | Liver carcinoma | 1 | CTD_human |
Hgene | A2M | C2609414 | Acute kidney injury | 1 | CTD_human |